share_log
Moomoo 24/7 ·  Apr 18 12:59
Chemomab Therapeutics Shares Are Trading Higher After the Company Announced the Publication of a New Study Reinforcing the Clinical Association of Its CCL24 Target With Disease Severity and Mortality in Patients With Systemic Sclerosis
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment